Summary

Persistence Market Research has recently released a comprehensive report on the Continuous Glucose Monitoring Systems Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Continuous Glucose Monitoring Systems Market Size (2024E): USD 12.0 Mn
• Projected Market Value (2031F):USD 22.4 Mn
• Global Market Growth Rate (CAGR 2024-2031): 9.3%

Continuous Glucose Monitoring Systems Market - Report Scope:

Continuous Glucose Monitoring Systems play a crucial role in the management of diabetes, offering real-time insights into glucose levels and trends. These systems provide continuous monitoring without the need for frequent fingerstick tests, enhancing convenience and improving glycemic control for individuals with diabetes. The Continuous Glucose Monitoring Systems market caters to individuals, healthcare facilities, and homecare settings, offering a range of monitoring devices and accompanying software solutions.
Market growth is driven by several key factors, including the increasing prevalence of diabetes globally, rising awareness about the importance of continuous glucose monitoring in diabetes management, and technological advancements enhancing system accuracy and usability. Additionally, the growing adoption of telemedicine and remote monitoring solutions further accelerates market expansion, enabling individuals with diabetes to access continuous care and support from healthcare providers.

Market Growth Drivers:

The global Continuous Glucose Monitoring Systems market is propelled by growing diabetes prevalence, particularly type 1 and type 2 diabetes, necessitating continuous glucose monitoring for effective disease management and prevention of complications. The integration of advanced sensors, wearable devices, and data analytics capabilities into Continuous Glucose Monitoring Systems enhances user experience, enabling real-time glucose monitoring, trend analysis, and personalized insights to optimize therapy decisions.
Furthermore, the expansion of reimbursement coverage for Continuous Glucose Monitoring Systems and the introduction of innovative financing models improve affordability and accessibility, driving market penetration across diverse patient populations. The convergence of Continuous Glucose Monitoring Systems with digital health platforms, mobile applications, and connected devices facilitates seamless data integration, remote monitoring, and patient engagement, fostering market growth and innovation.

Market Restraints:

Despite significant growth prospects, the Continuous Glucose Monitoring Systems market faces challenges related to regulatory approval, reimbursement policies, and interoperability issues with existing diabetes management systems. Stringent regulatory requirements governing the safety, accuracy, and reliability of Continuous Glucose Monitoring Systems impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and time-to-market for new products.
Moreover, limited reimbursement coverage for Continuous Glucose Monitoring Systems in certain regions and variability in reimbursement policies across payers create barriers to market access and adoption, particularly for individuals with limited financial resources or inadequate insurance coverage. Addressing these regulatory and economic challenges requires collaboration between industry stakeholders, regulatory agencies, and healthcare policymakers to establish standardized guidelines, promote reimbursement parity, and enhance patient access to Continuous Glucose Monitoring Systems.

Market Opportunities:

The Continuous Glucose Monitoring Systems market presents significant growth opportunities driven by technological innovations, consumer preferences, and evolving healthcare delivery models. The integration of artificial intelligence, machine learning, and predictive analytics into Continuous Glucose Monitoring Systems enables personalized diabetes management, proactive risk identification, and early intervention strategies to improve clinical outcomes and reduce healthcare costs.
Furthermore, the expansion of Continuous Glucose Monitoring Systems beyond diabetes management, including applications in gestational diabetes, prediabetes, and intensive care settings, broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective Continuous Glucose Monitoring Systems are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic diabetes care landscape.

Competitive Intelligence and Business Strategy:

Leading players in the global Continuous Glucose Monitoring Systems market, including [Key Companies], focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to develop advanced monitoring solutions, including wearable sensors, continuous glucose monitors, and digital health platforms, catering to diverse patient needs and clinical requirements.
Collaborations with healthcare providers, diabetes management programs, and digital health startups facilitate market access and technology adoption, driving user engagement and improving patient outcomes. Moreover, emphasis on user-centric design, patient education, and data-driven insights enhances user experience and promotes long-term adherence to continuous glucose monitoring therapy.

Key Companies Profiled:

• Herbalife Nutrition
• GNC Holdings
• NOW Health
• Nutramax Laboratories
• Nature's Bounty
• Banyan Botanicals
• Source Naturals
• Nutramarks Inc
• Nature's Way Products
• Abbott
• Natural Immunogenics

Continuous Glucose Monitoring Systems Market Research Segmentation

By Component:
• Transmitters and Monitors
• Sensors
• Insulin Pump

By End User:
• Home Care Diagnostics
• Hospitals
• ICU/Critical Care

By Region:
• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Continuous Glucose Monitoring Systems Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Component Lifecycle Analysis
2.4. Continuous Glucose Monitoring Systems Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Vehicle Types
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Continuous Glucose Monitoring Systems Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2019-2023
3.2.2. Current Market Size Forecast, 2024-2031
3.3. Global Continuous Glucose Monitoring Systems Market Outlook: Component
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Component, 2019-2023
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2024-2031
3.3.3.1. Transmitters and Monitors
3.3.3.2. Sensors
3.3.3.3. Insulin Pump
3.4. Market Attractiveness Analysis: Component
3.5. Global Continuous Glucose Monitoring Systems Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019-2023
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2031
3.5.3.1. Home Care Diagnostics
3.5.3.2. Hospitals
3.5.3.3. ICU/Critical Care
3.6. Market Attractiveness Analysis: End User
4. Global Continuous Glucose Monitoring Systems Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019-2023
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2024-2031
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Continuous Glucose Monitoring Systems Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
5.3.1. By Country
5.3.2. By Component
5.3.3. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2031
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2024-2031
5.5.1. Transmitters and Monitors
5.5.2. Sensors
5.5.3. Insulin Pump
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2031
5.6.1. Home Care Diagnostics
5.6.2. Hospitals
5.6.3. ICU/Critical Care
5.7. Market Attractiveness Analysis
6. Europe Continuous Glucose Monitoring Systems Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
6.3.1. By Country
6.3.2. By Component
6.3.3. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2031
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2024-2031
6.5.1. Transmitters and Monitors
6.5.2. Sensors
6.5.3. Insulin Pump
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2031
6.6.1. Home Care Diagnostics
6.6.2. Hospitals
6.6.3. ICU/Critical Care
6.7. Market Attractiveness Analysis
7. East Asia Continuous Glucose Monitoring Systems Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
7.3.1. By Country
7.3.2. By Component
7.3.3. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2031
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2024-2031
7.5.1. Transmitters and Monitors
7.5.2. Sensors
7.5.3. Insulin Pump
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2031
7.6.1. Home Care Diagnostics
7.6.2. Hospitals
7.6.3. ICU/Critical Care
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Continuous Glucose Monitoring Systems Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
8.3.1. By Country
8.3.2. By Component
8.3.3. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2031
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2024-2031
8.5.1. Transmitters and Monitors
8.5.2. Sensors
8.5.3. Insulin Pump
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2031
8.6.1. Home Care Diagnostics
8.6.2. Hospitals
8.6.3. ICU/Critical Care
8.7. Market Attractiveness Analysis
9. Latin America Continuous Glucose Monitoring Systems Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
9.3.1. By Country
9.3.2. By Component
9.3.3. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2031
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2024-2031
9.5.1. Transmitters and Monitors
9.5.2. Sensors
9.5.3. Insulin Pump
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2031
9.6.1. Home Care Diagnostics
9.6.2. Hospitals
9.6.3. ICU/Critical Care
9.7. Market Attractiveness Analysis
10. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
10.3.1. By Country
10.3.2. By Component
10.3.3. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024-2031
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Component, 2024-2031
10.5.1. Transmitters and Monitors
10.5.2. Sensors
10.5.3. Insulin Pump
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024-2031
10.6.1. Home Care Diagnostics
10.6.2. Hospitals
10.6.3. ICU/Critical Care
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2024
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Herbalife Nutrition
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. GNC Holdings
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. NOW Health
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Nutramax Laboratories
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Nature's Bounty
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Banyan Botanicals
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Source Naturals
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Nutramarks Inc
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Nature's Way Products
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Abbott
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Natural Immunogenics
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations